Literature DB >> 10718306

Galanin-(1-16) modulates 5-HT1A receptors in the ventral limbic cortex of the rat.

Z Díaz-Cabiale1, J A Narváez, U B Finnman, I Bellido, S O Ogren, K Fuxe.   

Abstract

The aim of the present study was to evaluate whether galanin-(1-16) of the rat and porcine type and rat galanin-(1-29) can modulate the 5-HT1A receptors, using [3H]8-OH-DPAT as a radioligand, in membrane preparations from the ventral limbic cortex of the rat. Galanin-(1-16) produced a concentration dependent increase in the Kd value of [3H]8-OH-DPAT binding sites with a maximal effect of approximately 61% at 30 nM without changing the Bmax values. The galanin antagonist M35 blocked these effects. Rat galanin produced the same pattern of response but was less potent and effective. These results indicate the existence of a galanin receptor subtype in the ventral limbic cortex mainly recognizing N-terminal galanin fragments and capable of more strongly modulating 5-HT1A receptors than cloned galanin receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718306     DOI: 10.1097/00001756-200002280-00018

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  2 in total

1.  A role for galanin N-terminal fragment (1-15) in anxiety- and depression-related behaviors in rats.

Authors:  Carmelo Millón; Antonio Flores-Burgess; Manuel Narváez; Dasiel O Borroto-Escuela; Luis Santín; Concepción Parrado; José Angel Narváez; Kjell Fuxe; Zaida Díaz-Cabiale
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

2.  On the existence and function of galanin receptor heteromers in the central nervous system.

Authors:  Kjell Fuxe; Dasiel O Borroto-Escuela; Wilber Romero-Fernandez; Alexander O Tarakanov; Feliciano Calvo; Pere Garriga; Mercé Tena; Manuel Narvaez; Carmelo Millón; Concepción Parrado; Francisco Ciruela; Luigi F Agnati; José A Narvaez; Zaida Díaz-Cabiale
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-26       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.